posted
Well this seems to be the low on this one going up from here. The company has huge potential. We should be hearing some good news from isreal on the clinical trials and then the FDA approval system in isreal is so much like it is here in the US. 0.30 doesnt seem very far.
posted
Well The Phase one is quite close to completion. This company has always been safe from side effects problems. I dont think anyone would waste millions anually on research if they dint see anything promising.
IP: Logged |